Vitreomacular Interface after Anti-Vascular Endothelial Growth Factor Injections in Neovascular Age-Related Macular Degeneration. [electronic resource]
Producer: 20151016Description: 1569-72 p. digitalISSN:- 1549-4713
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Bevacizumab
- Female
- Follow-Up Studies
- Humans
- Incidence
- Intravitreal Injections
- Macula Lutea -- pathology
- Male
- Middle Aged
- Prospective Studies
- Ranibizumab
- Receptors, Vascular Endothelial Growth Factor -- therapeutic use
- Recombinant Fusion Proteins -- therapeutic use
- Tissue Adhesions
- Tomography, Optical Coherence
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Vitreous Body -- pathology
- Vitreous Detachment -- diagnosis
- Wet Macular Degeneration -- drug therapy
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.